NO124602B - - Google Patents
Download PDFInfo
- Publication number
- NO124602B NO124602B NO264271A NO264271A NO124602B NO 124602 B NO124602 B NO 124602B NO 264271 A NO264271 A NO 264271A NO 264271 A NO264271 A NO 264271A NO 124602 B NO124602 B NO 124602B
- Authority
- NO
- Norway
- Prior art keywords
- dioxide
- iodinine
- phenazinediol
- lower alkyl
- benzyl
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 9
- NBMOVCYIGUDQJE-UHFFFAOYSA-N iodinin Chemical compound C1=CC=C2[N+]([O-])=C3C(O)=CC=CC3=[N+]([O-])C2=C1O NBMOVCYIGUDQJE-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 150000002988 phenazines Chemical class 0.000 claims description 4
- 230000002152 alkylating effect Effects 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- JOXNFMAXWAPITK-UHFFFAOYSA-N 1,6-dihydroxyphenazine Chemical compound C1=CC=C2N=C3C(O)=CC=CC3=NC2=C1O JOXNFMAXWAPITK-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001430355 Brevibacterium iodinum Species 0.000 description 1
- BMINBRPDZDJGSU-UHFFFAOYSA-N C(C)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC Chemical compound C(C)OC1=CC=CC2=NC3=C(C=CC=C3N=C12)OCC BMINBRPDZDJGSU-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000007361 Wohl-Aue reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- -1 benzyl halide Chemical class 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- JIDVGUQUQSOHOL-UHFFFAOYSA-N myxin Chemical compound C1=CC=C2[N+]([O-])=C3C(OC)=CC=CC3=[N+]([O-])C2=C1O JIDVGUQUQSOHOL-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO264271A NO124602B (xx) | 1966-11-25 | 1971-07-09 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59679466A | 1966-11-25 | 1966-11-25 | |
| NO17069767A NO123528B (xx) | 1966-11-25 | 1967-11-24 | |
| NO264271A NO124602B (xx) | 1966-11-25 | 1971-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124602B true NO124602B (xx) | 1972-05-08 |
Family
ID=27352611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO264271A NO124602B (xx) | 1966-11-25 | 1971-07-09 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO124602B (xx) |
-
1971
- 1971-07-09 NO NO264271A patent/NO124602B/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2363351C2 (de) | Substituierte 5(6)-Hydroxy-benzimidazol-2-carbaminsäuremethylester und diese enthaltende Heilmittel | |
| DE2442829A1 (de) | Tetracyclische verbindungen und verfahren zu ihrer herstellung | |
| JPH0469634B2 (xx) | ||
| NO170280B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater | |
| DE2812625A1 (de) | Oximderivate der 3-acetoxymethyl-7- aminothiazolyl-acetamido-cephalosporansaeure, ihre herstellung und pharmazeutische mittel | |
| EP0127763B1 (de) | Tricyclische Ether, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel | |
| DE2015573B2 (de) | a-AminomethyI-3-(hydroxy-, acyloxy- oder acyloxymethyl)- 4-acyloxybenzylalkohole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| NO142671B (no) | Alfa-azidobenzylpenicillinestere for bruk ved fremstilling av terapeutisk virksomme alfa-aminobenzylpenicillinestere | |
| SU1122230A3 (ru) | Способ получени производных пенициллановой кислоты или их аддитивных солей с кислотами | |
| DE2733291A1 (de) | (3-amino-5-substituiert-6-fluorpyrazinoyl- oder -pyrazinamido)-guanidine und ihre an den guanidino-stickstoffatomen substituierten derivate | |
| NO124602B (xx) | ||
| DE2641388A1 (de) | Verfahren zur herstellung von derivaten des 3', 4'-dideoxykanamycins b | |
| DE1793336C3 (de) | D-Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2612287A1 (de) | Aminoglykosid-antibiotika, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen | |
| EP0455596B1 (de) | Substituierte Indole | |
| EP0022504B1 (de) | 1-N-Alkylsisomicin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2951912C2 (xx) | ||
| US3200143A (en) | Quaternary ammonium compounds | |
| DE3008257A1 (de) | Verfahren zur herstellung von penicillansaeure-1,1-dioxid und dessen estern sowie zwischenstufen zur durchfuehrung des verfahrens | |
| DE2620777A1 (de) | Neue derivate des 1-hydroxy-benzo-2,3, 1-diazaborins und verfahren zu deren herstellung | |
| DE1795724C3 (de) | Verfahren zur Herstellung von 1-Hydroxy-6-niederalkoxy-phenazin-5,10-dioxiden | |
| DE2421488A1 (de) | Sulfonylderivate des erythromycins | |
| DE1913124A1 (de) | Alpha-Carboline und Verfahren zu ihrer Herstellung | |
| DE3842250A1 (de) | Tromethamin-salz von 1-methyl-ss-oxo-(alpha)-(phenylcarbamoyl)-2- pyrrolpropionitril | |
| DE2323722A1 (de) | Salze von sulfonen der 2,5-dihydroxybenzolmonosulfonsaeure und 2,5-dihydroxybenzoldisulfonsaeure |